• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去γ-羧基凝血酶原和甲胎蛋白阳性状态作为肝细胞癌肝切除术后新的预后指标

Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.

作者信息

Shimada M, Takenaka K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Sugimachi K

机构信息

Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

出版信息

Cancer. 1996 Nov 15;78(10):2094-100. doi: 10.1002/(sici)1097-0142(19961115)78:10<2094::aid-cncr9>3.0.co;2-o.

DOI:10.1002/(sici)1097-0142(19961115)78:10<2094::aid-cncr9>3.0.co;2-o
PMID:8918402
Abstract

BACKGROUND

The aim of this study was to elucidate the usefulness of measuring the positive status of both des-gamma-carboxy prothrombin (DCP) and alpha-fetoprotein (AFP) preoperatively as a new prognostic indicator of hepatocellular carcinoma (HCC).

METHODS

One hundred forty-seven patients who underwent curative hepatic resection for primary HCC were studied. The definitions of DCP and AFP positivity were: positive DCP > 0.1 AU/ml, and positive AFP > 50 ng/ml. The patients were classified into four groups according to their levels of positivity for DCP and/or AFP: Group 1 (n = 59), negative levels of both DCP and AFP; Group 2 (n = 28), negative DCP and positive AFP levels; Group 3 (n = 31), positive DCP and negative AFP levels; and Group 4 (n = 29), positive levels of both DCP and AFP.

RESULTS

Patient survival and disease free survival in Group 4 were the worst among the four groups. By multivariate analysis, using Cox proportional hazards model, both the DCP- and AFP-positive status (in combination) and poorly differentiated histology were independent factors of poor prognosis for patient survival; and DCP- and AFP-positive status (in combination), poorly differentiated histology, positive intrahepatic metastasis, and tumor diameter over 5 cm were independent factors of poor prognosis for disease free survival.

CONCLUSIONS

The combination of DCP- and AFP-positive status is a new prognostic indicator for patients with HCC after hepatic resection.

摘要

背景

本研究的目的是阐明术前检测去γ-羧基凝血酶原(DCP)和甲胎蛋白(AFP)阳性状态作为肝细胞癌(HCC)新的预后指标的实用性。

方法

对147例行原发性HCC根治性肝切除术的患者进行研究。DCP和AFP阳性的定义为:DCP阳性>0.1 AU/ml,AFP阳性>50 ng/ml。根据患者DCP和/或AFP的阳性水平将其分为四组:第1组(n = 59),DCP和AFP均为阴性;第2组(n = 28),DCP阴性且AFP阳性;第3组(n = 31),DCP阳性且AFP阴性;第4组(n = 29),DCP和AFP均为阳性。

结果

第4组患者的生存率和无病生存率在四组中最差。通过多因素分析,采用Cox比例风险模型,DCP和AFP阳性状态(联合)以及低分化组织学是患者生存预后不良的独立因素;DCP和AFP阳性状态(联合)、低分化组织学、肝内转移阳性以及肿瘤直径超过5 cm是无病生存预后不良的独立因素。

结论

DCP和AFP阳性状态的联合是肝切除术后HCC患者新的预后指标。

相似文献

1
Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.去γ-羧基凝血酶原和甲胎蛋白阳性状态作为肝细胞癌肝切除术后新的预后指标
Cancer. 1996 Nov 15;78(10):2094-100. doi: 10.1002/(sici)1097-0142(19961115)78:10<2094::aid-cncr9>3.0.co;2-o.
2
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.术前甲胎蛋白和脱γ-羧基凝血酶原在肝细胞癌患者中的预后作用
World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.
3
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.血浆去γ-羧基凝血酶原水平高且血清甲胎蛋白水平低的肝细胞癌患者的独特临床特征。
Cancer. 2000 Apr 1;88(7):1557-64. doi: 10.1002/(sici)1097-0142(20000401)88:7<1557::aid-cncr9>3.0.co;2-g.
4
The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma.肿瘤标志物评分是复发性肝细胞癌患者生存的独立预测指标。
Surg Today. 2015 Dec;45(12):1513-20. doi: 10.1007/s00595-014-1102-2. Epub 2014 Dec 20.
5
Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.术前甲胎蛋白和脱γ-羧基凝血酶原联合检测预测乙型肝炎相关肝细胞癌患者根治性切除术后复发。
Int J Cancer. 2012 Nov 15;131(10):2332-41. doi: 10.1002/ijc.27507. Epub 2012 Mar 28.
6
Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.甲胎蛋白和异常凝血酶原阳性状态:复发性肝细胞癌的重要预后因素。
World J Surg. 2004 Jul;28(7):702-7. doi: 10.1007/s00268-004-7205-y. Epub 2004 Jun 8.
7
Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone.甲胎蛋白-L3呈血清阳性且去γ-羧基凝血酶原呈血清阴性的肝细胞癌患者与仅去γ-羧基凝血酶原呈血清阳性的患者的临床病理特征比较
J Gastroenterol Hepatol. 2002 Jul;17(7):772-8. doi: 10.1046/j.1440-1746.2002.02806.x.
8
Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.同时测定甲胎蛋白和异常凝血酶原在肝细胞癌中的应用价值
Semin Surg Oncol. 1996 May-Jun;12(3):160-3. doi: 10.1002/(SICI)1098-2388(199605/06)12:3<160::AID-SSU3>3.0.CO;2-5.
9
Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.使用修订的酶免疫测定试剂盒测定的血清去γ-羧基凝血酶原水平,其相对于孤立性肝细胞癌的临床病理特征具有更高的灵敏度。
Cancer. 2000 Feb 1;88(3):544-9.
10
Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma.去γ-羧基凝血酶原与肝细胞癌的增殖活性
Surgery. 1995 Jun;117(6):682-91. doi: 10.1016/s0039-6060(95)80013-1.

引用本文的文献

1
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.肿瘤标志物评分对预测接受阿替利珠单抗联合贝伐单抗治疗的肝细胞癌患者预后的价值:一项多中心回顾性研究
Cancers (Basel). 2023 Aug 31;15(17):4348. doi: 10.3390/cancers15174348.
2
Pure laparoscopic liver resection versus percutaneous radiofrequency ablation for small hepatocellular carcinoma: a propensity score and multivariate analysis.单纯腹腔镜肝切除术与经皮射频消融术治疗小肝细胞癌的倾向评分及多因素分析
Transl Cancer Res. 2022 Jan;11(1):43-51. doi: 10.21037/tcr-21-1045.
3
Altered epidermal fatty acid-binding protein expression in hepatocellular carcinoma predicts unfavorable outcomes.
肝细胞癌中表皮脂肪酸结合蛋白表达改变预示不良预后。
Cancer Manag Res. 2018 Nov 23;10:6275-6284. doi: 10.2147/CMAR.S181555. eCollection 2018.
4
Outcomes following liver resection for multinodular Barcelona Clinic Liver Cancer-B hepatocellular carcinoma.多结节巴塞罗那临床肝癌B期肝细胞癌肝切除术后的结局
Oncol Lett. 2018 Nov;16(5):6383-6392. doi: 10.3892/ol.2018.9420. Epub 2018 Sep 7.
5
Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.巴塞罗那临床肝癌分期 B 期肝癌行肝切除术的生存结局。
World J Surg Oncol. 2017 Aug 22;15(1):156. doi: 10.1186/s12957-017-1229-x.
6
Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.脂肪酸结合蛋白5通过诱导上皮-间质转化在肝细胞癌中发挥作用。
Cancer Med. 2017 May;6(5):1049-1061. doi: 10.1002/cam4.1020. Epub 2017 Apr 4.
7
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.术前甲胎蛋白和脱γ-羧基凝血酶原在肝细胞癌患者中的预后作用
World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.
8
The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma.肿瘤标志物评分是复发性肝细胞癌患者生存的独立预测指标。
Surg Today. 2015 Dec;45(12):1513-20. doi: 10.1007/s00595-014-1102-2. Epub 2014 Dec 20.
9
Serum vascular endothelial growth factor level in patients with hepatocellular carcinoma undergoing liver transplantation: experience of a single Western center.接受肝移植的肝细胞癌患者血清血管内皮生长因子水平:一家西方单一中心的经验
Int J Organ Transplant Med. 2012;3(1):42-51.
10
Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.血清内皮细胞蛋白 C 受体作为肝细胞癌患者的新型预后生物标志物。
J Cancer. 2014 Mar 4;5(3):221-30. doi: 10.7150/jca.7691. eCollection 2014.